Jurenka, J.; Nagyová, A.; Dababseh, M.; Mihalov, P.; Stankovič, I.; Boža, V.; Kravec, M.; Palkovič, M.; Čaprnda, M.; Sabaka, P.
Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infect. Dis. Rep. 2022, 14, 1004-1016.
https://doi.org/10.3390/idr14060100
AMA Style
Jurenka J, Nagyová A, Dababseh M, Mihalov P, Stankovič I, Boža V, Kravec M, Palkovič M, Čaprnda M, Sabaka P.
Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infectious Disease Reports. 2022; 14(6):1004-1016.
https://doi.org/10.3390/idr14060100
Chicago/Turabian Style
Jurenka, Ján, Anna Nagyová, Mohammad Dababseh, Peter Mihalov, Igor Stankovič, Vladimír Boža, Marián Kravec, Michal Palkovič, Martin Čaprnda, and Peter Sabaka.
2022. "Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study" Infectious Disease Reports 14, no. 6: 1004-1016.
https://doi.org/10.3390/idr14060100
APA Style
Jurenka, J., Nagyová, A., Dababseh, M., Mihalov, P., Stankovič, I., Boža, V., Kravec, M., Palkovič, M., Čaprnda, M., & Sabaka, P.
(2022). Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infectious Disease Reports, 14(6), 1004-1016.
https://doi.org/10.3390/idr14060100
